Kurimchak A.M., Shelton C., Herrera-Montavez C., Duncan K.E., Chernoff J. ,Duncan J.S., Intrinsic resistance to mek inhibition through bet protein mediated kinome reprogramming in nf1-deficient ovarian cancer. Mol Cancer Res. 17(8): 1721-1734, 2019. PMC6679760. 4.484
Zawistowski J.S., Bevill S.M., Goulet D.R., Stuhlmiller T.J., Beltran A.S., Olivares-Quintero J.F., Singh D., Sciaky N., Parker J.S., Rashid N.U., Chen X., Duncan J.S., Whittle M.C., Angus S.P., Velarde S.H., Golitz B.T., He X., Santos C., Darr D.B., Gallagher K., Graves L.M., Perou C.M., Carey L.A., Earp H.S.,J ohnson G.L., Enhancer remodeling during adaptive bypass to mek inhibition is attenuated by pharmacologic targeting of the p-tefb complex. Cancer Discov. 7(3): 302-321, 2017. PMC5340640. 26.370
Duncan, JS. Whittle, MC. Nakamura, K. Abell, AN. Midland, AA. Zawistowski, JS. Johnson, NL. Granger, DA. Vincent, NJ. Darr, DB. Usary, J. Kuan, PF. Smalley, DM. Major, B. He, X. Hoadley, K. Zhou, B. Sharpless, NE. Perou, CM. Kim, WY. Gomez, SM. Chen, X. Jin, J. Frye, SV. Earp, HS. Graves, LM. Johnson, GL. (2012) Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple negative breast cancer. Cell. 149(2): 307-321. PubMed
Duncan, JS. Turowec, JP. Wu, C. Duncan, KE. Vilk, G. Wu, C. Luscher, B. Li, SC. Gloor, GB. Litchfield, DW. (2011) A peptide-based target screen implicates the protein kinase CK2 in the global regulation of caspase signaling. Sci Signal, 4(172): ra30 PubMed